Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy

Details for Australian Patent Application No. 2007340129 (hide)

Owner Pharmacyclics, Inc.

Inventors Buggy, Joseph J.; Magda, Darren; Miller, Richard; Adimoolam, Shanthi

Agent Spruson & Ferguson

Pub. Number AU-B-2007340129

PCT Pub. Number WO2008/082856

Priority 60/871,900 26.12.06 US

Filing date 7 December 2007

Wipo publication date 10 July 2008

Acceptance publication date 2 February 2012

International Classifications

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/166 (2006.01) - having the carbon atom of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

23 July 2009 PCT application entered the National Phase

  PCT publication WO2008/082856 Priority application(s): WO2008/082856

2 February 2012 Application Accepted

  Published as AU-B-2007340129

31 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007340137-Hub and spoke burner port configuration

2007340128-Haptic for accommodating intraocular lens